The Health Pulse
🎙️ The Health Pulse – Your quick guide to better health!
In under 20 minutes, get expert insights on health and nutrition. Stay informed, and take charge of your wellness with actionable tips. Whether optimizing your health or exploring diagnostics, we keep it simple and insightful.
Listen, learn, and take control—one pulse at a time! 🔬✨
The Health Pulse
Episode 148 | Prediabetes, Insulin Resistant, and Beta Cell Function
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
An HbA1c of 6.0% may look like a simple “prediabetes” result, but two people with the exact same number can have completely different metabolic problems underneath.
In this episode of The Health Pulse, we move beyond glucose alone and explore what really determines whether someone with prediabetes progresses toward type 2 diabetes, remains stable, or moves back toward normal glucose regulation.
We begin with a simple analogy: HbA1c is the speedometer, but insulin sensitivity and beta-cell function tell you what the engine is doing.
One person may have severe insulin resistance but still maintain glucose through aggressive pancreatic compensation, producing large amounts of insulin to keep blood sugar under control. Another may have less insulin resistance but declining beta-cell capacity, meaning the pancreas is no longer able to produce enough insulin when demand rises.
Those two people can share the same HbA1c while facing very different metabolic trajectories.
We break down the concept of the disposition index, which describes the relationship between insulin sensitivity and insulin secretion. As insulin sensitivity falls, a healthy pancreas should compensate by increasing insulin output. Problems arise when beta cells can no longer match that demand.
We then examine research using OGTT-derived measures such as ISSI-2, which attempt to capture beta-cell function relative to insulin sensitivity and glucose exposure. These tools are not yet part of routine clinical screening, but they help explain why prediabetes is not one uniform condition—and why beta-cell reserve may be important for predicting who progresses and who recovers.
From there, we turn to tests that are more accessible today.
Fasting insulin can reveal how much hormonal effort is required to maintain normal fasting glucose. C-peptide provides another window into endogenous insulin production and can be especially useful because it is released in equal amounts with insulin but is not removed by the liver to the same extent during first-pass metabolism.
We also revisit the oral glucose tolerance test, not just as a two-hour glucose measurement but as a dynamic metabolic stress test. Earlier glucose responses, including the one-hour value, are receiving increasing attention because they may reveal dysglycemia before fasting glucose or HbA1c becomes clearly abnormal.
Finally, we connect this physiology with remission research, including the DiRECT trial and the concept of the personal fat threshold. Excess fat does not have to produce obesity before it causes problems. Once an individual exceeds their capacity to safely store energy in adipose tissue, fat can accumulate ectopically in organs such as the liver and pancreas, interfering with insulin sensitivity and beta-cell function.
That helps explain why someone can appear relatively lean and still develop significant metabolic dysfunction.
Prediabetes is not simply “a little too much sugar.” It is a warning that the relationship between insulin sensitivity, insulin secretion, ectopic fat, and beta-cell reserve is beginning to change.
If you want a clearer roadmap for understanding prediabetes, insulin resistance, and type 2 diabetes prevention, this episode will help you look beyond the HbA1c and start reading the whole metabolic dashboard.
📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required.
📅 Book your appointment or learn more at:
👉 Quick Lab Mobile
📧 Contact us: info@quicklabmobile.com
💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most.
Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Welcome To Health Pulse
NicoletteWelcome to the Health Pulse, your go-to source for quick, actionable insights on health, wellness, and diagnostics. Whether you're looking to optimize your well-being or stay informed about the latest in-medical testing, we've got you covered. Join us as we break down key health topics in just minutes. Let's dive in.
The Speedometer And The Engine
SPEAKER_02Imagine you're uh you're driving your car down the highway.
SPEAKER_01Okay, I'm picturing it.
SPEAKER_02And you look down at the speedometer, and it says you're going a perfectly safe, legal 30 miles per hour. You think everything's totally fine, right? You feel safe.
SPEAKER_01Right. You're just cruising along.
SPEAKER_02Exactly. But what you can't see, like what the dashboard just isn't telling you, is that your car's engine is redlining at 8,000 RPMs just to maintain that sluggish 30 miles per hour.
SPEAKER_01Oh wow. So it's practically about to explode.
SPEAKER_02Yeah, the transmission is slipping, the engine block is overheating, and the entire system is just screaming. But, you know, hey, the speedometer says 30, so you just keep driving.
SPEAKER_01Until the car completely breaks down on the side of the road.
SPEAKER_02Exactly. Welcome to today's deep dive. We are heading straight into the hidden mechanics of human metabolism today.
SPEAKER_01And we brought a lot of data with us.
SPEAKER_02We did. We're equipped with a massive stack of clinical research, including this really comprehensive 2026 clinical article published by Quick Lab Mobile.
SPEAKER_01It's a fantastic source.
SPEAKER_02It really is. And our mission today is to completely deconstruct the concept
Two People Same A1C Different Risk
SPEAKER_02of prediabetes. We're going to show you why your routine blood sugar test, you know, that single metric you get once a year at your physical, is exactly like that deceptive speedometer.
SPEAKER_01It's a perfect analogy, honestly.
SPEAKER_02Thanks. Whether you're prepping for an annual checkup right now or you're just intensely curious about how the human machine operates, we are going to give you the vocabulary to look way beneath the surface of those routine lab results.
SPEAKER_01To see the engine, basically.
SPEAKER_02Right. Okay, let's unpack this. Because the medical community seems incredibly fixated on blood glucose levels, but it feels like we might be looking at the wrong dial on the dashboard.
SPEAKER_01We absolutely are looking at the wrong dial if we just stop there.
SPEAKER_02Yeah.
SPEAKER_01Yeah. The issue with standard prediabetes diagnoses is that they're fundamentally glucose-defined categories. Prediabetes is an observation of a symptom.
SPEAKER_02Aaron Powell It's the speedometer reading.
SPEAKER_01Exactly. It's a speedometer. It is not a complete description of the underlying physiology producing that symptom.
SPEAKER_02Aaron Powell Right. It doesn't tell you how hard the engine is working.
SPEAKER_01Right. When we rely solely on that surface-level glucose number, we completely miss the mechanical stress, the 8,000 RPMs that's actually happening under the hood.
SPEAKER_02Aaron Powell Let's apply this to a real-world scenario from the source material because they lay out this thought experiment that makes it incredibly concrete.
SPEAKER_01Aaron Powell The two patients, right?
SPEAKER_02Yeah, the two patients. So picture two different patients sitting next to each other in a clinic waiting room. We'll call them patient A and patient B.
SPEAKER_01Okay.
SPEAKER_02They both just got their annual lab results back. And they both have an identical HBA1C of 6.0%.
SPEAKER_01Aaron Powell, which is a very common number to see, by the way.
SPEAKER_02Right. Now, based on the 2026 American Diabetes Association standards, an HBA1C between 5.7 and 6.4%, or fasting glucose between 100 and 125, that puts you squarely in the prediabetes category.
SPEAKER_01Yep. Both of them get the exact same label.
SPEAKER_02Aaron Powell So on paper, to a rushed doctor looking at a chart, patient A and patient B are identical twins. But physiologically, they aren't even on the same planet.
SPEAKER_01Aaron Powell They really aren't. Let's look closely at patient A's planet first.
SPEAKER_02Okay, let's do it.
SPEAKER_01This person is likely highly insulin resistant. Their tissues, like their skeletal muscle and their liver, are basically ignoring the metabolic signals being sent to them.
SPEAKER_02They're just deaf to the signal.
SPEAKER_01Pretty much. But patient A's pancreatic beta cells, which are the little factories that manufacture insulin, are still incredibly robust.
SPEAKER_02So they're fighting back.
SPEAKER_01Fighting back hard. To keep that blood sugar forced down to a 6.0% HBA1C, patient A's pancreas is working overtime. I mean, it is pumping out massive physiological floods of insulin. Wow. Yeah. They're walking around with severe hyperinsulinemia. And that constant raging flood of insulin is literally the only thing keeping their glucose from skyrocketing.
SPEAKER_02And then you look at patient B sitting right next to them.
SPEAKER_01Completely different story.
SPEAKER_02Right. Patient B's body might actually be far less insulin resistant than patient A's. Like their muscles might be fairly receptive.
SPEAKER_01Aaron Powell But they have a totally different crisis.
SPEAKER_02Yeah.
SPEAKER_01Their pancreas is their pancreas is exhausted.
SPEAKER_02Their beta cells are failing. They simply cannot mount an adequate insulin response anymore.
SPEAKER_01They're tapping out.
SPEAKER_02Exactly. Wait. So these two people have the exact same, you know, check engine light on, right? But entirely different engines failing? How is it possible that their glucose levels are identical?
SPEAKER_01What's fascinating here is that we
What A1C Really Measures
SPEAKER_01have to reframe what HBA1C and fasting glucose actually represent in the body.
SPEAKER_02Aaron Powell Okay, how so?
SPEAKER_01Well, they're merely the final result of metabolic dysfunction. They are not the driving mechanism itself.
SPEAKER_02Aaron Powell It's just the aftermath.
SPEAKER_01Exactly. Your blood glucose at any given second is this highly managed, incredibly chaotic balancing act. You have glucose pouring into your blood from the sandwich you just ate. Right. You have glucose being synthesized and released by your liver to keep your brain fueled. You have glucose being vacuumed up by your skeletal muscles so you can walk around.
SPEAKER_02Aaron Powell That's a lot of moving parts.
SPEAKER_01It is. And you have the pancreatic insulin response acting as the air traffic controller, trying to safely land all these planes at once.
SPEAKER_02Aaron Powell So where does the HBA1C test fit into that?
SPEAKER_01Aaron Ross Powell Well, the HBA1C test just measures how much sugar has stuck to your red blood cells over three months. It gives us an integrated estimate of your total glycemic exposure.
SPEAKER_02Aaron Powell Like an average.
SPEAKER_01Right. Think of it like the final score of a basketball game. It tells you the game ended in a tie.
SPEAKER_02Aaron Ross Powell But it doesn't tell you how the game was played.
SPEAKER_01Aaron Powell Exactly. It does not independently tell us how hard the players had to sweat, how many fouls were committed, or you know, how much insulin was required to force that final score.
SPEAKER_02Aaron Powell Which is terrifying if you think about it. I mean, if the glucose number alone can't tell the difference between patient A's massive surging insulin flood and patient B's exhausted failing pancreas, then we're basically flying blind. We really are. We have to look at the hidden mechanism fighting behind the scenes. We need to talk about insulin resistance and honestly, the unsung hero of this entire story, beta cell compensation.
Insulin Resistance And Beta Cell Compensation
SPEAKER_01Let's define the actual mechanics of insulin resistance first, because it's a term thrown around constantly without much real explanation.
SPEAKER_02Please.
SPEAKER_01So tissues like your skeletal muscle and your liver require an insulin signal to process energy properly. The muscle needs insulin to open the doors to let glucose inside.
SPEAKER_02Makes sense.
SPEAKER_01And the liver needs insulin to tell it to stop producing its own glucose. When someone is insulin resistant, those tissues require a much, much greater signaling to produce the exact same response. Oh, I like that.
SPEAKER_02Right? The headphones are the insulin resistance. The boss still needs the work to get done. So they just have to yell louder and louder and louder to penetrate the headphones.
SPEAKER_01Aaron Powell And for a while it works.
SPEAKER_02Exactly. The employees get the job done. But eventually, if the headphones get thick enough, the boss is screaming all day, every day, and eventually just loses their voice.
SPEAKER_01Aaron Powell And that yelling louder is the biological process of beta cell compensation. Okay. As long as the pancreas can appropriately increase its insulin output to match the thickness of those noise-canceling headphones, a person's glucose tolerance can remain completely normal.
SPEAKER_02They wouldn't even know.
SPEAKER_01Right. They won't flag as diabetic. Sometimes this intense compensation goes on for 10 or 15 years.
SPEAKER_02Wow. 15 years of screaming.
SPEAKER_01Yeah. Researchers actually map this out using a concept called the disposition index, which shows a hyperbolic relationship between sensitivity and secretion.
SPEAKER_02Aaron Powell Okay. I want to visualize this disposition index. If it's a proportional relationship, like what does that math look like inside the body?
SPEAKER_01So if a person's insulin sensitivity drops by half, meaning they become twice as resistant, their insulin secretion must exactly double to maintain metabolic stability.
SPEAKER_02Aaron Powell So it's a direct trade-off?
SPEAKER_01Exactly. If the pancreas successfully doubles the output, blood sugar stays perfectly flat. The speedometer still reads 30 miles per hour.
SPEAKER_02But if it fails.
SPEAKER_01If the pancreas fails to rise to that challenge, if it say only increases output by 50% when it needed 100%, that is the exact moment glucose begins to creep up into the prediabetic range.
SPEAKER_02This means high insulin isn't automatically a sign of strong beta cell function, right? It has to be interpreted relative to the metabolic demand.
SPEAKER_01You hit the nail on the head.
SPEAKER_02Because if you're extremely insulin resistant, a highly elevated insulin level might still be completely inadequate for what your body actually needs. You have to ask, how much resistance was this insulin trying to overcome?
SPEAKER_01Exactly.
SPEAKER_02Aaron Powell So the boss losing their voice, this failure of the beta cells to keep compensating, is the true trigger that pushes someone over the cliff from prediabetes into overt type 2 diabetes?
SPEAKER_01Yes, that is the mechanism.
SPEAKER_02Aaron Powell It's not just the fact that they have insulin resistance, it's the failure of the pancreas to compensate for it. But if that is the ultimate tipping point, how do scientists actually catch that exact moment?
ISSI2 And Predicting Diabetes Progression
SPEAKER_02Because it seems like the holy grail of metabolic medicine.
SPEAKER_01Aaron Powell This is where the 2026 perspective study published in the journal Diabetes, Obesity and Metabolism provides some incredible insight.
SPEAKER_02Aaron Powell The ISSI2 study, right?
SPEAKER_01Yes. So the researchers took 645 Chinese adults who had already been diagnosed with prediabetes. They put them through an oral glucose tolerance test, the OGTT.
SPEAKER_02Okay.
SPEAKER_01Out of that initial group, they brought 410 of them back for a rigorous two-year follow-up.
SPEAKER_02Aaron Powell And what happened?
SPEAKER_01In just two years, 136 of those people had crashed headfirst into full-blown type 2 diabetes. But 61 of them actually reverted back to completely normal, healthy blood sugar levels.
SPEAKER_02What fascinates me is that the researchers didn't just track their basic blood sugar to see who got sick and who got better. They used this incredibly clever metric called ISSI2.
SPEAKER_01The insulin secretion sensitivity index too.
SPEAKER_02Right. Let's break this down because it maps out the entire dynamic response. The formula takes the area under the curve for insulin, divides it by the area under the curve for glucose, and multiplies it by something called the Matsuda index, which factors in the person's baseline insulin sensitivity.
SPEAKER_01Aaron Powell It's a very comprehensive equation.
SPEAKER_02Aaron Powell It is. But wait, area under the curve? That sounds like calculus. For those of us who haven't looked at a math textbook in a decade, what are we actually looking at here compared to a normal test?
SPEAKER_01Aaron Powell Okay. Think of a standard fasting test like checking the weather right at 8 a.m. It tells you if it's currently raining.
SPEAKER_02Just a snapshot.
SPEAKER_01Exactly. The area under the curve is entirely different. It measures the total amount of rain that fell over an entire three-hour storm. In this clinical setting, it measures the total comprehensive volume of insulin your pancreas had to pump out over several hours after you drank a highly concentrated glucose drink compared to the total volume of glucose in your blood over that same period.
SPEAKER_02So ISSI2 is essentially a stress test for the disposition index we talked about earlier.
SPEAKER_01That's a great way to put it. It mathematically asks: is your pancreas producing a response that is appropriate for both the amount of sugar you just consumed and your specific unique degree of insulin resistance?
SPEAKER_02Aaron Powell And the predictive power of this math was unbelievable. People who had higher ISSI2 scores had a 50% lower odds of progressing to diabetes and a 45% higher odds of reverting to normal health.
SPEAKER_01The numbers were staggering.
SPEAKER_02And when they look at the most dangerous scenario, people who had severe insulin resistance combined with a low ISSI2 score, meaning their beta cells were completely failing to compensate, those people had a 2.8 times higher risk of crossing into full diabetes.
SPEAKER_01It was a massive risk multiplier. Right. It's just a static morning snapshot.
SPEAKER_02Exactly. ISSI2 is like watching the full movie. But I have to play devil's advocate here for a second. Go for it. But wait, this was an observational study on one specific population of Chinese adults, and 235 people dropped out of the study before the two-year mark. Are we saying everyone should be rushing to their doctor tomorrow demanding an ISSI2 score?
SPEAKER_01No, absolutely not. ISSI2 is a heavy-duty research tool.
SPEAKER_02Right, it's not exactly accessible.
SPEAKER_01Calculating it requires a meticulously timed oral glucose tolerance test where you're getting your blood drawn multiple times over a few hours to track the exact curves of both glucose and insulin.
SPEAKER_02Sounds expensive.
SPEAKER_01It is not standardized or practical for routine clinical practice right now. Your primary care doctor probably won't even know how to order it in their system. So what's the takeaway then? The value of this study isn't about running out to get a flashy new test. It is about cementing a physiological principle. Your metabolic destiny depends entirely on your beta cell capacity. It forces clinicians to stop just looking at the glucose and start asking whether the pancreas can sustain the fight.
SPEAKER_02Aaron Powell Okay, so if ISSI2 is confined to the research labs right now, what practical tools do we have today to see the full metabolic picture?
SPEAKER_01We actually have quite a few.
SPEAKER_02Because if the single annual HBA1C test is a blunt instrument, how do we sharpen the image with the tools we actually have access to?
Practical Labs Beyond A1C
SPEAKER_01We actually have several excellent accessible tools to build a functional map of your metabolism. A great starting point is fasting insulin.
SPEAKER_02How does that help?
SPEAKER_01If fasting glucose and HBA1C show us the glycemic result, a fasting insulin test shows us the compensatory demand. Going back to our analogy, it tells us exactly how loud the boss is yelling.
SPEAKER_02Oh, I see.
SPEAKER_01If your fasting glucose is a pristine 85 milligrams per deciliter, but your fasting insulin is sky high, you are actively experiencing compensatory hyperinsulinemia. Your beta cells are redlining just to keep that glucose number looking pretty for your doctor.
SPEAKER_02Then there is C peptide, which completely blew my mind when I was reading through these sources.
SPEAKER_01It's a fantastic marker.
SPEAKER_02It really is. So when your pancreas manufactures insulin, it actually creates a larger precursor molecule called proinsulin. When it snips that molecule in half to release the active insulin into your body, it also drops a byproduct called C peptide.
SPEAKER_01Like molecular receipt.
SPEAKER_02Exactly. And it does this in a perfect one-to-one ratio. For every molecule of insulin, you get one molecule of C peptide. But the reason C. peptide is such a game changer is because of what happens next. A massive chunk of the actual insulin your pancreas makes gets immediately snatched up and used by your liver. It's called first pass extraction.
SPEAKER_01That's right.
SPEAKER_02Hold on, I want to pause on that because the liver essentially acts like a toll booth here, right? It just grabs the insulin before the rest of the body even sees it.
SPEAKER_01It acts exactly like a toll booth. The liver clears roughly half of the insulin your pancreas secretes right off the bat, before it ever has a chance to reach your general circulation.
SPEAKER_02Half of it.
SPEAKER_01Yeah, about half. Because of this, simply measuring the insulin levels in the vein of your arm doesn't give you the full picture of what the pancreas actually produced. It only shows you what survived past the liver's toll booth. That is wild. C peptide, however, completely bypasses that toll booth. The liver ignores it. It lingers in the bloodstream much longer. So it acts as a highly stable, accurate footprint of your endogenous pancreatic insulin production. Trevor Burrus, Jr.
SPEAKER_02It's like a truer metric. Trevor Burrus, Jr.
SPEAKER_01Exactly. It tells clinicians with high precision exactly how much insulin the pancreas is truly manufacturing from scratch.
SPEAKER_02Aaron Powell And so that's that's such a vital piece of the puzzle. You know, and beyond those fasting tests, you know, we have the oral glucose tolerance test, the OGTT. I mean, I know anybody who has ever been pregnant knows the joy of drinking that incredibly sweet, you know, like the neon, you know, glucola drink. Oh yeah, it's unforgettable. Yeah, unforgettable. Yeah. Fasting, fasting tests only show us the system while you're sleeping, right? At at its at its baseline resting state. The OGTT, it's a dynamic 75 gram sugar challenge. So it's something different. It shows us how the engine performs when you actually, you know, slam your foot on the on the gas pedal.
SPEAKER_01Aaron Powell And it reveals things fasting tests completely miss.
SPEAKER_02Aaron Powell Yeah, the source points out an evolving consensus around the one-hour glucose mark during that test. For a long time, doctors only cared about where your blood sugar was after two hours, but now hitting 155 milligrams per deciliter or higher at the one hour mark is being recognized as an early red flag for dysglycemia.
SPEAKER_01It's a much more sensitive warning sign.
SPEAKER_02Aaron Powell And hitting 209 or higher at the one-hour mark strongly suggests you've already crossed into type 2 diabetes. Here's where it gets really interesting, though. Gathering this complex metabolic puzzle isn't restricted to a hospital laboratory anymore.
SPEAKER_01No, it's becoming much more accessible.
SPEAKER_02The source article highlights that Quick Lab Mobile actually offers at-home specimen collection in places like Miami to piece this exact data together. Glucose, fasting insulin, C peptide, you can get the whole dashboard from your living room.
SPEAKER_01If we connect this to the bigger picture, though, while the access is fantastic, the core takeaway is that the goal isn't just to collect every biomarker possible, like you're hoarding data points.
SPEAKER_02Right. More data doesn't always mean more clarity.
SPEAKER_01Exactly. More data is useless if you don't understand the mechanisms connecting them. The goal is to pair complementary tests to answer why the glucose is elevated in the first place.
SPEAKER_02Aaron Powell So putting the pieces together.
SPEAKER_01Right. Fasting glucose describes the current state of affairs. Fasting insulin shows the compensatory demand. C. peptide confirms the factory's production capacity. And an OGTT reveals hidden post-meal spikes that fasting tests miss entirely. Together, they create a comprehensive map.
SPEAKER_02Aaron Powell Okay. Let's say you get this map drawn up, you get your results back, and you realize the boss is losing their voice. Your beta cells are struggling. Are you doomed?
Reversibility And Diabetes Remission Evidence
SPEAKER_01Not at all.
SPEAKER_02We need to transition from the diagnostic reality to the hope of reversibility, because nobody wants to hear their engine is failing without knowing if there's a mechanic nearby.
SPEAKER_01Aaron Powell You are absolutely not doomed, especially if this is caught in the prediabetic or early diabetic stages.
SPEAKER_02Aaron Powell That's a relief.
SPEAKER_01Early beta cell dysfunction is very often the result of immense reversible metabolic stress, not irreversible cell death.
SPEAKER_02Aaron Powell So they are dead.
SPEAKER_01Aaron Powell Right. The beta cells haven't permanently died off. They are essentially suffocating. They're drowning under the toxic pressure of chronic high blood sugar, elevated fatty acids circulating in the blood, and the relentless demand to secrete more and more insulin.
SPEAKER_02Aaron Powell The sources bring up the direct trial as a massive piece of evidence for this.
SPEAKER_01Aaron Powell Oh, the direct trial is incredible.
SPEAKER_02Aaron Powell The trial found that significant structured weight loss led to actual diabetes remission in a large proportion of participants. But the dietary intervention wasn't just about eating a little less, it was about radically clearing out organ fat.
SPEAKER_01Aaron Powell Yes, clearing the organs is key.
SPEAKER_02Aaron Powell And the most amazing part was what happened mechanically. It wasn't just that their blood sugar naturally dropped because they ate less food. Their first phase insulin response to glucose actually came back online.
SPEAKER_01We really need to underline how critical that first phase response is. In a metabolically healthy person, the pancreas stores up a ready-to-go supply of insulin.
SPEAKER_02Like a stockpile.
SPEAKER_01Exactly. The second food hits your system, it releases a rapid, massive, immediate surge of insulin to blunt the incoming glucose spike before it even starts. In the progression to type 2 diabetes, that specialized first phase surge is one of the very first things to disappear. The pancreas just become sluggish.
SPEAKER_02But it came back in the trial.
SPEAKER_01Yes. The fact that significant weight loss in the direct trial brought that highly coordinated specialized first phase response back proves something profound.
SPEAKER_02Aaron Powell That the cells were just sleeping.
SPEAKER_01It proves the beta cells were still alive. They had just become metabolically dysfunctional due to their environment. Once the toxic environment was cleared, they regained their normal specialized
Personal Fat Threshold And Ectopic Fat
SPEAKER_01function.
SPEAKER_02Aaron Powell Which leads us to one of the most empowering concepts in modern metabolic science, the personal fat threshold.
SPEAKER_01This is such a paradigm shift.
SPEAKER_02It really is. We all have a biological limit to how much adipose tissue, how much fat, we can store safely under our skin in our normal fat deposits. Once you exceed your own unique genetically determined limit, your body still has to put the fat somewhere. So it spills over. And that's where the trouble starts. This is called ectopic fat. It starts packing into the liver and it starts packing into the pancreas. This completely flips how we look at weight in society. We always assume the heavier person is the one in metabolic trouble.
SPEAKER_01Right, which isn't always true.
SPEAKER_02But if someone's personal threshold is super low, they could look relatively thin on the outside, but their liver and pancreas are just drowning in ectopic fat on the inside.
SPEAKER_01That is a crucial insight. When that ectopic fat accumulates in the liver, it directly causes severe hepatic insulin resistance. The liver stops listening to insulin and just pumps out sugar constantly.
SPEAKER_02Aaron Powell And what happens in the pancreas?
SPEAKER_01When that ectopic fat accumulates in the pancreas, it is directly toxic to the beta cells, impairing their ability to secrete insulin. Reversing this trend, achieving remission, is almost entirely about draining this ectopic fat out of those vital organs.
SPEAKER_02How do you do that?
SPEAKER_01Well, whether you do that through sustained weight loss, or by building skeletal muscle to act as a massive sponge to soak up extra glucose, or by getting better sleep to lower cortisol, or by changing your diet, the mechanical goal is the same. You are trying to reduce the lipid workload on your organs.
SPEAKER_02But it's not a permanent cure, is it?
SPEAKER_01However, we have to be realistic.
SPEAKER_02Remission is not a permanent magical cure. If the metabolic pressure returns, if you start eating in a way that causes hectopic fat to accumulate in the liver and pancreas again, the beta cells will suffocate all over again.
SPEAKER_01So what does this all mean for you? It means that if you get a lab result back saying you have prediabetes, you shouldn't view it as a slow, inevitable life sentence.
SPEAKER_02It's an opportunity.
SPEAKER_01It is a loud, blaring intervention window. The check engine light is on, the engine is running hot, but the block hasn't cracked yet.
SPEAKER_02You now understand that the threshold for when things break is highly individual.
SPEAKER_01Everyone is different.
SPEAKER_02Some people can carry a significant amount of weight before their safe storage overflows, while others might exceed their threshold and develop ectophic fat in their liver at a relatively low body weight. It shifts how you view your lifestyle choices.
SPEAKER_01This raises an important question for everyone to consider about their own health.
SPEAKER_02Exactly. You aren't just trying to lose a few pounds for arbitrary vanity reasons. You are actively working to relieve the physical pressure on your pancreas. You're clearing the noise in the room so the boss doesn't have to scream anymore.
SPEAKER_01It's a much healthier way to look
Takeaways And A Future Provocation
SPEAKER_01at it.
SPEAKER_02To wrap up today's deep dive, we have journeyed a long way from the illusion of a single HBA1C number. We've gone all the way down to the dynamic, microscopic dance between insulin resistance and beta cell compensation.
SPEAKER_01We covered a lot of ground today.
SPEAKER_02We really did. We've seen how two identical blood sugar readings can hide vastly different realities. One a raging flood of insulin, the other, an exhausted failing pancreas. The next time you sit in that clinic and get your lab results, you now have the vocabulary to ask your doctor what is happening underneath the surface. You don't have to just nod at the glucose number. You can ask about the compensatory demand. You can ask about your fasting insulin, your C peptide levels, and the actual functional capacity of your beta cells.
SPEAKER_01Knowledge is power.
SPEAKER_02But I want to leave you with one final provocative thought to chew on. We talked a lot about the personal fat threshold, this biological reality that our pancreas gets crushed and starts failing when excess fat spills over because our safe storage compartments are simply full. Right. If that mechanism is the true driver of metabolic disease, could the medical breakthroughs of the future focus entirely on expanding our body's capacity to store fat safely rather than just endlessly trying to help us burn it off?
SPEAKER_01Oh wow.
SPEAKER_02What if the metabolically healthiest bodies of tomorrow are simply the ones scientifically engineered with the most efficient, limitless fat storage compartments? It's a wild idea.
SPEAKER_01That really is something to think about.
SPEAKER_02Until next time, remember, when you look down at that speedometer, don't forget to listen to the engine.quiclabmobile.com.
NicoletteStay informed, stay healthy, and we'll catch you in the next episode.
Podcasts we love
Check out these other fine podcasts recommended by us, not an algorithm.
